Skip to main content
. 2021 Apr 1;11:629646. doi: 10.3389/fonc.2021.629646

Figure 3.

Figure 3

Meta-analysis of pooled odds ratios of a tumor response to anti–PD-1 versus anti–PD-L1 therapy. (A) ORR, (B) DCR.